PetVivo Holdings announced it will be exhibiting at the Veterinary Orthopedic Society annual conference to be held March 11th to Marth 18th, 2023 at the Yellowstone Conference Center in Big Sky, Montana. PetVivo intends to exhibit its lead product, SPRYNG with OsteoCushion Technology, a medical device injection of sterilized, extra-cellular matrix microparticles that are lubricious and spongy used in the treatment of lameness and other joint related afflictions, such as osteoarthritis. The VOS plays host to many of the top industry professionals involved in veterinary orthopedics. Furthermore, Erik Kleemam DVM, MPH, of Ethos Veterinary Health, will be a presenter for the 2023 VOS Annual Conference in Big Sky, Montana. Dr. Kleeman will be presenting on "Evaluating the Benefit and Tolerability of an Intra-Articular Injection of a Collagen-Elastin Biomaterial into the Stifle Joint of Dogs with Suspected Cruciate Ligament Rupture."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PETV:
- PetVivo Holdings, Inc. to Exhibit and Dr. Erik Kleeman of Ethos Veterinary Health to Present Canine Study Results at the Veterinary Orthopedic Society Annual Conference
- PetVivo to exhibit SPRYNG at Western Veterinary Conference
- PetVivo Reports Third Quarter of Fiscal 2023 Financial Results
- PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2022
- PETVIVO HOLDINGS, INC. TO PARTICIPATE IN THE LYTHAM PARTNERS INVESTOR SELECT CONFERENCE
